在Lag3中引起厌恶的注意力眼:抑郁症的诊断和治疗方法
Yingying Wang1,2, Qi Wang1, Lijie Chen1,2
1Department of Psychiatry and Psychology, General Hospital of Northern Theater Command, Shenyang, Liaoning, China.
Frontiers in psychiatry
|April 17, 2025
概括
厌恶的面孔显著损害了抑郁症患者的注意力,注意力眼效应在300毫秒的滞后预测了抑郁症的严重程度. 这表明抑郁症是一种潜在的诊断和治疗工具.
科学领域:
- 认知神经科学 认知神经科学
- 临床心理学 临床心理学
- 精神病学是一个精神病学.
背景情况:
- 注意力缺陷是诊断抑郁症的关键指标.
- 在评估与抑郁症相关的注意力缺陷方面,情绪诱导的注意力闪范式的实用性需要进一步探索.
研究的目的:
- 调查情绪诱导的注意眼模式在评估不同程度抑郁症患者注意力缺陷方面的有效性.
- 为了确定特定的情绪分心和时间滞后是否与抑郁症严重程度相关.
主要方法:
- 32名轻度抑郁,32名严重抑郁和32名健康对照参与了这项研究.
- 在100ms,300ms和700ms滞后的情绪分心 (厌恶,恐惧,悲伤,中立) 中使用目标识别来评估注意力.
- 采用了接收器操作特征 (ROC) 分析.
主要成果:
- 抑郁症患者表现出更大的注意力障碍与厌恶的面孔,导致更强的注意力眼效应.
- 注意力眼效应在300毫秒的滞后时间与厌恶的面孔 (D3) 强烈预测了抑郁症的严重程度.
- 在ROC分析中,曲线下的面积 (AUC) 值为0.75 (没有抑郁症),0.61 (轻度抑郁症) 和0.73 (严重抑郁症).
结论:
- 注意力眼效应,特别是在300毫秒的延迟下厌恶的面孔,可以成为识别和评估抑郁症的宝贵工具.
- 这种效应也可能成为注意力偏差修改训练在抑郁症治疗中的潜在目标.
相关概念视频
Long-term Depression
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Long-term Depression
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over time, all...
Calcium Ion Concentration Mechanism
If over time, all...
Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Depressive Disorders: Etiology
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...


